The effects of different purinergic agonists on the cardiac adenosi'/> Purinergic facilitation of ATP-sensitive potassium current in rat ventricular myocytes
首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Purinergic facilitation of ATP-sensitive potassium current in rat ventricular myocytes
【2h】

Purinergic facilitation of ATP-sensitive potassium current in rat ventricular myocytes

机译:嘌呤能促进大鼠心室肌细胞中ATP敏感性钾电流

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

class="enumerated" style="list-style-type:decimal">The effects of different purinergic agonists on the cardiac adenosine 5′-triphosphate (ATP)-sensitive potassium current (IK(ATP)), appearing during dialysis of rat isolated ventricular myocytes with a low-ATP (100 μM) internal solution under whole-cell patch-clamp conditions, were examined in the presence of a P1 purinoceptor antagonist.The extracellular application of ATP in the micromolar range induced, besides known inward currents through cationic and chloride channels, the facilitation of IK(ATP) once IK(ATP) had already been partially activated during the low-ATP dialysis.Analogues of ATP, α,β-methyleneadenosine 5′-triphosphate (α,βmeATP), 2-methylthioadenosine triphosphate (2MeSATP), adenosine 5′-O-3-thiotriphosphate (ATPγS) similarly facilitated IK(ATP). UTP and ADP were very weak agonists while AMP and adenosine had no detectable effect.The half-maximal stimulating concentration (C50) of α,βmeATP, an analogue that did not elicite the interfering inward cationic current was 1.5 μM. Similar apparent C50 (1–2 μM) were observed for ATP and analogues tested with somewhat less maximal effect of ATPγS.Suramin, a nonselective P2-purinoceptor antagonist, altered IK(ATP) at the relatively high concentration required to inhibit purinoceptors. Pyridoxal-phosphate-6-azophenyl-2′,4′-disulphonic acid (PPADS), a supposedly predominantly P2X-purinoceptor antagonist, at micromolar concentration inhibited the transient inward current but did not block the facilitation of IK(ATP).Our results demonstrate that ATP and its analogues facilitate IK(ATP) in rat ventricular myocytes by stimulation of non-P1-, non-P2X-purinoceptors.
机译:class =“ enumerated” style =“ list-style-type:decimal”> <!-list-behavior =枚举前缀-word = mark-type = decimal max-label-size = 0-> 不同的嘌呤能激动剂对大鼠低心ATP(100μm)内部溶液透析的心室肌细胞在全脂条件下透析时对心脏腺苷5'-三磷酸(ATP)敏感的钾电流(IK(ATP))的影响在P1嘌呤受体拮抗剂的存在下检查细胞膜片钳的条件。在低ATP透析过程中,一旦IK(ATP)已被部分激活,就会激活ATP。 ATP,α,β-亚甲基腺苷5'-三磷酸(α,βmeATP),2-甲基硫代腺苷三磷酸( 2MeSATP),腺苷5'-O-3-硫代三磷酸(ATPγS)类似地促进IK(ATP)。 UTP和ADP是非常弱的激动剂,而AMP和腺苷则没有检测到的作用。 α,βmeATP的半数最大刺激浓度(C50)(不引起阳离子内向干扰电流的类似物)为1.5微米对于ATP及其类似物,观察到相似的表观C50(1-2µM),但对ATPγS的最大作用较小。 苏拉明,一种非选择性P2-嘌呤受体拮抗剂,在相对较高的浓度下改变了IK(ATP)。需要抑制嘌呤受体。在微摩尔浓度下,据称主要是P2X-嘌呤受体拮抗剂吡rid醛-磷酸-6-偶氮苯基-2',4'-二磺酸(PPADS)抑制了瞬时内向电流,但没有阻止IK(ATP)的促进。 li> 我们的结果表明,ATP及其类似物可通过刺激非P1,非P2X嘌呤受体来促进大鼠心室肌细胞IK(ATP)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号